Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-05-20
FTSVForty Seven, Inc.McCamish Mark AnthonyPres, CEOS - Sale+OE$12.10-16,50060,719-21%-$199,726
2019-05-20
EOLSEvolus, Inc.Romine KristineDirP - Purchase$19.25+40,56280,909+101%+$780,819
2019-05-20
EOLSEvolus, Inc.Blank SimoneDirP - Purchase$19.25+628,536923,560+213%+$12,099,318
2019-05-20
NGMNgm Biopharmaceuticals IncGoeddel David VDir, 10%P - Purchase$13.50+50,00015,759,0140%+$675,000
DM
2019-05-20
BGNEBeigene, Ltd.Huang JaneCMO, HematologyS - Sale+OE$130.07-2,500271,621-1%-$325,168
2019-05-20
ADROAduro Biotech, Inc.Ferber CelesteSVP, GC, SecretaryS - Sale$3.21-2,00029,436-6%-$6,413
2019-05-20
NGMNgm Biopharmaceuticals IncSvennilson PeterDir, 10%P - Purchase$13.50+50,00015,589,0140%+$675,000
D
2019-05-21
BGNEBeigene, Ltd.Liang HowardCFO, Chief Strategy OfficerS - Sale+OE$130.21-23,20052,338-31%-$3,020,860
2019-05-20
NGMNgm Biopharmaceuticals IncColumn Group L P10%P - Purchase$13.50+50,00015,584,0140%+$675,000
M
2019-05-20
MDCOMedicines Co /deDenner Alexander JDirP - Purchase$33.89+431,0004,067,000+12%+$14,606,470
2019-05-21
ARWRArrowhead Pharmaceuticals, Inc.Myszkowski Kenneth AllenCFOS - Sale$22.00-27,071278,536-9%-$595,562
2019-05-20
LGNDLigand Pharmaceuticals IncAryeh JasonDirP - Purchase$112.01+250116,2370%+$28,003
2019-05-20
ADMPAdamis Pharmaceuticals CorpCarlo Dennis J PhdPres,amp; CEOS - Sale$1.73-11,184620,999-2%-$19,339
2019-05-20
ADMPAdamis Pharmaceuticals CorpDaniels Karen K.VP of OperationsS - Sale$1.73-5,591174,353-3%-$9,670
2019-05-20
ADMPAdamis Pharmaceuticals CorpMoss Ronald B.Chief Medical OfficerS - Sale$1.77-8,741276,255-3%-$15,464
2019-05-20
ADMPAdamis Pharmaceuticals CorpMarguglio David J.SVP, Chief Business OfficerS - Sale$1.77-8,735387,583-2%-$15,464
2019-05-20
ADMPAdamis Pharmaceuticals CorpHopkins Robert OCFOS - Sale$1.73-7,559340,348-2%-$13,109
M
2019-05-20
AGLEAeglea Biotherapeutics, Inc.Quinn Anthony G.Pres, CEOP - Purchase$6.77+26,592321,738+9%+$180,032
M
2019-05-20
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.01+43,00021,877,3970%+$472
M
2019-05-20
ETONEton Pharmaceuticals, Inc.Brynjelsen SeanPres, CEOP - Purchase$7.93+10,0001,044,940+1%+$79,326
2019-05-20
UROVUrovant Sciences Ltd.Dexxon Holdings Ltd.10%P - Purchase$8.05+10,00045,448,8390%+$80,525
DM
2019-05-20
MGNXMacrogenics IncRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$18.54-4,00030,806-11%-$74,157
M
2019-05-20
NVUSNovus Therapeutics, Inc.Turkel Catherine C.PresS - Sale$1.95-9,53788,662-10%-$18,612
M
2019-05-20
NVUSNovus Therapeutics, Inc.Kuwahara JonSee RemarksS - Sale$1.95-5,2765,974-47%-$10,296
M
2019-05-20
NVUSNovus Therapeutics, Inc.Flesher Gregory J.CEOS - Sale$1.95-14,638156,918-9%-$28,566
2019-05-21
BSTCBiospecifics Technologies CorpWegman TobyDir, 10%S - Sale$64.06-5,500945,073-1%-$352,353
2019-05-21
BSTCBiospecifics Technologies CorpWegman Mark NDirS - Sale$64.04-6,00074,272-7%-$384,236
2019-05-21
PRNBPrincipia Biopharma Inc.Orbimed Advisors LLC10%S - Sale$30.25-1,000,0001,605,713-38%-$30,250,000
2019-05-21
BLPHBellerophon Therapeutics, Inc.Wang Theodore TDir, 10%P - Purchase$0.61+43,280506,979+9%+$26,371
2019-05-21
BLPHBellerophon Therapeutics, Inc.Peacock Jonathan MDirP - Purchase$0.61+20,0001,875,920+1%+$12,198
2019-05-21
BLPHBellerophon Therapeutics, Inc.Tenenbaum FabianCEOP - Purchase$0.59+5,000484,282+1%+$2,975
2019-05-21
SBPHSpring Bank Pharmaceuticals, Inc.Driscoll Martin JPres, CEOP - Purchase$6.63+5,00075,400+7%+$33,150
2019-05-20
AKRXAkorn IncMeyer Steven JDirP - Purchase$4.10+15,000167,339+10%+$61,500
2019-05-17
BSTCBiospecifics Technologies CorpChao Jennifer MDirS - Sale$63.72-4,0001,313-75%-$254,860
D
2019-05-17
AMRNAmarin Corp PlcukStack David MDirS - Sale+OE$18.00-13,1740-100%-$237,139
D
2019-05-20
GWPHGw Pharmaceuticals PlcKnappertz VolkerChief Medical OfficerS - Sale+OE$14.64-12,14485,824-12%-$177,846
D
2019-05-20
GWPHGw Pharmaceuticals PlcGiacobello Scott M.CFOS - Sale+OE$14.52-4,22487,096-5%-$61,332
2019-05-20
PLXPPlx Pharma Inc.Valentino Michael JExec COBP - Purchase$5.60+44,404196,790+29%+$248,662
2019-05-21
APVOAptevo Therapeutics Inc.Grant Grady IIIDirP - Purchase$0.80+10,00010,000New+$7,970
D
2018-01-29
EYENEyenovia, Inc.Mario ErnestDirP - Purchase$10.00+90,000236,770+61%+$900,000
DM
2019-05-17
VNDAVanda Pharmaceuticals Inc.Polymeropoulos Mihael HristosPres, CEOS - Sale+OE$15.35-217,5151,211,455-15%-$3,338,725
2019-05-17
NOVNNovan, Inc.Novak AndrewVP, Accounting, Bus OpsP - Purchase$1.47+5,4006,700+415%+$7,938
2019-05-17
NOVNNovan, Inc.Gay John M.VP, Finance, Corp. ControllerP - Purchase$1.50+14,90015,000>999%+$22,350
M
2019-05-17
NOVNNovan, Inc.Stafford Paula BPres, COOP - Purchase$1.92+80,69380,693New+$154,633
2019-05-17
NOVNNovan, Inc.Martin G. KellyCEOP - Purchase$1.43+60,000100,000+150%+$85,800
M
2019-05-16
NATRNatures Sunshine Products IncWynnefield Partners Small Cap Value LP10%P - Purchase$9.70+5,0002,224,3750%+$48,492
2019-05-17
REPHRecro Pharma, Inc.Ajdler ArnaudDirP - Purchase$9.00+40,0001,112,501+4%+$360,000
M
2019-05-17
NERVMinerva Neurosciences, Inc.Index Venture Associates III Ltd10%S - Sale$6.02-22,9184,451,443-1%-$137,896
D
2019-05-15
XYNXynomic Pharmaceuticals Holdings, Inc.Xu PeixinFormer Dir. & 10% more ownerP - Purchase$0.00+108,9801,628,580+7%+$0
D
2019-05-15
XYNXynomic Pharmaceuticals Holdings, Inc.Bison Capital Holding Co LtdFormer 10% more ownerP - Purchase$0.00+108,9801,628,580+7%+$0
D
2019-05-20
TEVATeva Pharmaceutical Industries LtdDe Notaristefani CarloEVP Global OperationsS - Sale+OE$11.42-16,07033,589-32%-$183,519
M
2019-05-16
UROVUrovant Sciences Ltd.Viking Global Investors LP10%P - Purchase$7.54+21,6080-100%+$162,884
M
2019-05-16
UROVUrovant Sciences Ltd.Viking Global Performance LLC10%P - Purchase$7.54+21,6080-100%+$162,884
M
2019-05-16
UROVUrovant Sciences Ltd.Svf Investments (Uk) Ltd10%P - Purchase$7.54+21,60722,725,2770%+$162,876
2019-05-20
APVOAptevo Therapeutics Inc.White Marvin LPres, CEOP - Purchase$0.81+30,000243,603+14%+$24,300
D
2019-05-16
MRTXMirati Therapeutics, Inc.Donadio Jamie ASVP, CFOS - Sale+OE$75.00-7,500221-97%-$562,500
M
2019-05-16
UROVUrovant Sciences Ltd.Lo Andrew10%P - Purchase$7.54+21,60822,725,2770%+$162,884
2019-05-16
MTNBMatinas Biopharma Holdings, Inc.Stern Adam KDirP - Purchase$0.95+150,0006,833,475+2%+$142,500
2019-05-16
MTNBMatinas Biopharma Holdings, Inc.Lepore Patrick GDirP - Purchase$0.95+100,000100,000New+$95,250
2019-05-16
MTNBMatinas Biopharma Holdings, Inc.Conrad Herbert JDirP - Purchase$0.96+25,0004,079,922+1%+$24,115
M
2019-05-16
UROVUrovant Sciences Ltd.Qvt Associates Gp LLC10%P - Purchase$7.54+21,60822,725,2770%+$162,884
M
2019-05-16
UROVUrovant Sciences Ltd.Machado Patrick10%P - Purchase$7.54+21,60822,725,2770%+$162,884
M
2019-05-16
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$5.18+10,00036,958,5700%+$51,824
M
2019-05-16
TBPHTheravance Biopharma, Inc.O'Connor DonalDirS - Sale$20.46-4,00027,571-13%-$81,835
M
2019-05-16
UROVUrovant Sciences Ltd.Roivant Sciences Ltd.10%P - Purchase$7.54+21,60822,725,2770%+$162,884
2019-05-16
APLTApplied Therapeutics Inc.Shendelman ShoshanaPres, CEO, 10%P - Purchase$10.00+125,0004,876,379+3%+$1,250,000
D
2019-05-16
APLTApplied Therapeutics Inc.Marcus Joel SDirP - Purchase$10.00+150,000404,860+59%+$1,500,000
M
2019-05-16
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$8.95-1,8002,717,3190%-$16,105
D
2019-05-17
ZTSZoetis Inc.David GlennCFOS - Sale+OE$102.22-8,19110,549-44%-$837,284
2019-05-16
BMYBristol Myers Squibb CoSantiago Karen MurphyControllerS - Sale$47.56-3,0653,066-50%-$145,771
2019-05-16
BMYBristol Myers Squibb CoSamuels Theodore R. IIDirP - Purchase$47.29+5,00027,000+23%+$236,440
2019-05-20
CMRXChimerix IncSherman Michael A.CEOP - Purchase$3.48+30,00030,000New+$104,316
2019-05-17
ANIPAni Pharmaceuticals IncMarken James G.SVP Ops, Prod DevS - Sale$70.67-8,90761,230-13%-$629,458
2019-05-16
FIXXHomology Medicines, Inc.5Am Ventures Iv, L.P.10%S - Sale$21.47-615,000221,435-74%-$13,204,050
2019-05-16
FIXXHomology Medicines, Inc.Parmar KushDir, 10%S - Sale$21.47-615,000221,435-74%-$13,204,050
M
2019-05-16
UROVUrovant Sciences Ltd.Dexxon Holdings Ltd.10%P - Purchase$7.10+11,60845,424,3540%+$82,359
2019-05-16
MRNSMarinus Pharmaceuticals IncSmith Edward FCFOS - Sale$5.03-24,21120,097-55%-$121,781
2019-05-17
CRBPCorbus Pharmaceuticals Holdings, Inc.White BarbaraChief Medical OfficerP - Purchase$7.20+1,389185,548+1%+$10,001
D
2019-05-16
TEVATeva Pharmaceutical Industries LtdDe Notaristefani CarloEVP Global OperationsS - Sale+OE$11.76-62918,784-3%-$7,397
2019-05-17
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$2.08+50,000215,891,6330%+$103,931
2019-05-14
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$14.27-25,817729,879-3%-$368,409
2019-05-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$31.37-1,928164,463-1%-$60,481
2019-05-16
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$31.37-13,383295,736-4%-$419,825
2019-05-16
NKTRNektar TherapeuticsNicholson JohnSVP, COOS - Sale$31.37-4,077166,578-2%-$127,895
2019-05-16
NKTRNektar TherapeuticsLabrucherie Gil MSVP, CFOS - Sale$31.37-3,767127,935-3%-$118,171
2019-05-16
NKTRNektar TherapeuticsHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$31.37-2,44994,694-3%-$76,825
2019-05-16
NKTRNektar TherapeuticsDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$31.37-3,46195,913-3%-$108,572
D
2019-05-15
GWPHGw Pharmaceuticals PlcTovey Christopher J.COOS - Sale+OE$15.01-1,2002,503-32%-$18,012
M
2019-05-15
FTSVForty Seven, Inc.Majeti RavindraDirS - Sale$16.02-4,3111,421,4000%-$69,044
2019-05-16
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$8.53-22,702449,217-5%-$193,755
M
2019-02-15
AGLEAeglea Biotherapeutics, Inc.Quinn Anthony G.Pres, CEOP - Purchase$6.75+18,713295,146+7%+$126,399
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, CROS - Sale$165.41-6153,2620%-$10,090
M
2019-05-13
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.01+81,50021,834,3970%+$1,037
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, ControllerS - Sale$165.41-16117,928-1%-$26,631
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale$165.41-8335,0030%-$13,729
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaEVP, CMOS - Sale$165.41-24113,736-2%-$39,864
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP\Chief Commercial OfficerS - Sale$165.41-13333,3800%-$22,000
2019-05-15
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$165.41-9131,5530%-$15,052
D
2019-05-15
ALNYAlnylam Pharmaceuticals, Inc.Maraganore JohnCEOS - Sale+OE$70.00-49,457193,092-20%-$3,461,990
2019-05-15
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasDirS - Sale$12.84-25,000182,069-12%-$321,042
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top